The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical trial conduct! This comprehensive EDI Framework and Toolkit resource are the products of an expert working group comprised of 3CTN members, trial sponsors, and people with lived experience from underrepresented communities. The resulting materials are available and accessible on the 3CTN website for the benefit of all in the research community. To access, please go to https://3ctn.ca/equity-diversity-and-inclusion-in-clinical-trials/.
Fall 2025 Early Career Researcher Workshop – Applications Now Open
The CIHR Institute of Cancer Research is pleased to announce the open call for applications for its 2025 Early Career Researcher (ECR) Workshop, in partnership with the Canadian Cancer Research Alliance, Canadian Cancer Society, Cancer Research Society, Ontario Institute f... Read More »
The CIHR Institute of Cancer Research is pleased to announce the open call for applications for its 2025 Early Career Researcher (ECR) Workshop, in partnership with the Canadian Cancer Research Alliance, Canadian Cancer Society, Cancer Research Society, Ontario Institute f... Read More »
Are you a cancer patient, survivor, or caregiver who is interested in learning more about cancer research?
CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered virtually in the fall of 2021. This program is designed for cancer patients, survivors, and caregivers with an interest in learning more about cancer research and how they can contribute to the re... Read More »
CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered virtually in the fall of 2021. This program is designed for cancer patients, survivors, and caregivers with an interest in learning more about cancer research and how they can contribute to the re... Read More »